1. Home
  2. LCNB vs SABS Comparison

LCNB vs SABS Comparison

Compare LCNB & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

HOLD

Current Price

$15.97

Market Cap

234.5M

Sector

Finance

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.66

Market Cap

201.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCNB
SABS
Founded
1877
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.5M
201.4M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
LCNB
SABS
Price
$15.97
$3.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
17.7K
391.3K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
5.43%
N/A
EPS Growth
68.04
N/A
EPS
1.63
N/A
Revenue
$6,445,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$3.66
N/A
P/E Ratio
$9.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.75
$1.60
52 Week High
$17.89
$6.60

Technical Indicators

Market Signals
Indicator
LCNB
SABS
Relative Strength Index (RSI) 43.50 48.25
Support Level $15.92 $3.55
Resistance Level $16.44 $4.11
Average True Range (ATR) 0.48 0.23
MACD -0.08 -0.01
Stochastic Oscillator 14.29 43.94

Price Performance

Historical Comparison
LCNB
SABS

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: